We used the staining protocol to assess cDC1 abundance in PGE2-producing control (COX-competent) BRAFV600E and Ptgs1/Ptgs2−/− (COX-deficient) BRAFV600E melanoma tumors (Zelenay et al., 2015). The gene discussed is PTGS1; the disease is melanoma.